UROVANT SCIENCES LTD's ticker is UROV and the CUSIP is G9381B108. A total of 26 filers reported holding UROVANT SCIENCES LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,610,000 | +93.3% | 99,876 | +11.9% | 0.00% | – |
| Q3 2020 | $833,000 | -5.1% | 89,246 | 0.0% | 0.00% | – |
| Q2 2020 | $878,000 | +15.7% | 89,246 | +8.3% | 0.00% | – |
| Q1 2020 | $759,000 | -69.3% | 82,371 | -48.3% | 0.00% | – |
| Q4 2019 | $2,470,000 | +210.7% | 159,312 | +89.7% | 0.00% | – |
| Q3 2019 | $795,000 | +18.3% | 83,962 | -1.2% | 0.00% | – |
| Q2 2019 | $672,000 | +71.9% | 84,996 | +118.3% | 0.00% | – |
| Q1 2019 | $391,000 | – | 38,943 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|